Effect of Bladder Filling on Rectal Contractions During Cystometry
1 other identifier
observational
50
1 country
1
Brief Summary
Increasing knowledge on rectal motility and bladder-rectum cross-talk has been published in recent years. However, whether bladder filling factors during multichannel urodynamic studies affect rectal contraction (RC) parameters has not been studied. The primary aim of this study is to assess the impact of bladder filling and desire to void on rectal contraction amplitude or frequency. Secondary objectives are to determine any significant change in rectal parameters depending on clinical and urodynamic factors or treatment. All patients referred for urodynamic assessment and with studies positive for rectal contractions as defined by the international continence society (ICS) will be included. Abdominal pressure will be measured using a T-doc air charged abdominal catheter inserted 10 cm from the anal margin. Standardized urodynamic evaluation will be conducted following ICS guidelines. Mean amplitude, maximal amplitude (cmH20) and mean frequency of rectal contractions on all urodynamic studies will be visually measured on the recording software and compared depending on bladder sensation (First Desire to void (FDV), Strong Desire to Void (SDV) and filling volume (200ml, 400ml). Demographic data (age, sex, BMI), underlying neurological disease, clinical symptoms, and scores (Neurogenic Bladder Symptom Score, Bristol Score, Cleveland Score), urodynamic parameters and treatments will be collected. Time since last defecation and meal will also be collected. This prospective observational study will be conducted in a Neuro-Urology department of a French university hospital. All the patients included are referred for multichannel urodynamic assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2021
CompletedFirst Submitted
Initial submission to the registry
August 16, 2021
CompletedFirst Posted
Study publicly available on registry
August 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedFebruary 18, 2022
February 1, 2022
6 months
August 16, 2021
February 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Variation of the amplitude of rectal contraction function of bladder sensation 1
Difference of mean amplitude of rectal contraction between beginning of cystometry to first desire to void (FDV) and FDV to end of bladder filling (maximal capacity)
One day
Secondary Outcomes (6)
Variation of the amplitude of rectal contraction function of bladder sensation 2
one day
Variation of the amplitude of rectal contraction function of bladder sensation 3
One day
Variation of the amplitude of rectal contraction function of bladder sensation 4
One day
Frequency of rectal contraction function of bladder sensation
One day
Variation of the amplitude of rectal contraction function of bladder filling
One day
- +1 more secondary outcomes
Study Arms (1)
Patients included
Patients with lower urinary tract disorders assessed with multichannel cystometry and presence of rectal contractions. Measure of amplitude and frequency of rectal contractions function of the bladder sensation and volume of bladder filling.
Interventions
Observational study, standard record of need to void during cystometry
Eligibility Criteria
observational cohort of included patients
You may qualify if:
- age over 18
- lower urinary tract dysfunction requiring cystometry assessement
- rectal contraction during cystometry
You may not qualify if:
- Colo-rectal inflammatory or oncological disease
- History of colo-rectal surgery
- Irritable bowel syndrome
- Probe expulsion (during urodynamic study).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gérard Amarencolead
Study Sites (1)
department of Neuro-Urology, Hôpital Teno
Paris, 75020, France
Study Officials
- PRINCIPAL INVESTIGATOR
Gérard Amarenco, PUPH
Sorbonne Université, GRC 001, GREEN, AP-HP, Hôpital Tenon, Paris, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Neuro-Urology department, Tenon Hospital
Study Record Dates
First Submitted
August 16, 2021
First Posted
August 19, 2021
Study Start
March 10, 2021
Primary Completion
August 31, 2021
Study Completion
September 30, 2021
Last Updated
February 18, 2022
Record last verified: 2022-02